Your browser doesn't support javascript.
loading
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.
Liang, Jin-Hua; Wang, Wei-Ting; Du, Kai-Xin; Xing, Tong-Yao; Wang, Yan; Wang, Hui; Liu, Lu; Guo, Rui; Shao, Yang; Liang, Junheng; Li, Yue; Shen, Hao-Rui; Wang, Li; Li, Jian-Yong; Xu, Wei.
Afiliação
  • Liang JH; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Wang WT; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, 210029, China.
  • Du KX; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Xing TY; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Wang Y; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, 210029, China.
  • Wang H; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Liu L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Guo R; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, 210029, China.
  • Shao Y; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Liang J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Li Y; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, 210029, China.
  • Shen HR; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
  • Wang L; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, 210029, China.
  • Li JY; Key Laboratory of Hematology, Nanjing Medical University, Nanjing, 210029, China.
  • Xu W; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210029, China.
Hum Cell ; 36(2): 835-846, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36520345
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia / Linfoma Extranodal de Células T-NK Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Hum Cell Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Leucemia / Linfoma Extranodal de Células T-NK Tipo de estudo: Prognostic_studies Limite: Humans / Male / Middle aged Idioma: En Revista: Hum Cell Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China